AUSTIN, Texas, September 30, 2019 – Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that management will participate in one-on-one meetings at the 2019 Cantor Global Healthcare Conference, taking place October 2-4, 2019 in New York City.
For a link to the press release click here.